Viewing StudyNCT00338130



Ignite Creation Date: 2024-05-05 @ 4:53 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00338130
Status: COMPLETED
Last Update Posted: 2014-08-13
First Post: 2006-06-15

Brief Title: Randomised Study to Compare the Efficacy of AZD6244 vs TMZ
Sponsor: AstraZeneca
Organization: AstraZeneca

Conditions & Keywords Data

Conditions:
Name
Melanoma
Keywords:
Name View
temozolomide View
Melanoma View
Phase II View
AZD6244 View